𝔖 Bobbio Scriptorium
✦   LIBER   ✦

141 Assessment of Durability of Infliximab Maintenance Therapy in Children With Crohn's Disease

✍ Scribed by Marian D. Pfefferkorn; Trudy Lerer; David R. Mack; Jonathan Evans; David J. Keljo; Marsha H. Kay; Joel R. Rosh; Anthony R. Otley; Michael C. Stephens; Maria Oliva-Hemker; Neal S. Leleiko; Athos Bousvaros; Ryan Carvalho; Farhat N. Ashai-Khan; Andrew B. Grossman; Shehzad A. Saeed; Meredith C. Hitch; Michael Kappelman; Boris Sudel; William A. Faubion; James Markowitz; Jeffrey S. Hyams


Book ID
119432985
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
97 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term outcome of maintenance inflixi
✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i